Tests allergen testing to choose allergy shots
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study checks how well a newer, detailed allergy test (using specific allergen components) can guide whether you should get allergy immunotherapy (allergy shots) for things like dust mites or grass pollen. It may help patients get the right treatment plan by improving how doctors confirm what allergens are driving symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a medical need for allergy shots (immunotherapy) for allergic hay-fever type symptoms (rhinoconjunctivitis) or asthma
- You are older than 5 years
- Your allergy tests show you have IgE sensitization—often from a positive skin prick test and/or a blood IgE test
- Your allergy shots are meant for house dust mites and/or grass pollen (other allergens can be present)
- You have not done allergen immunotherapy (allergy shots) before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
This study uses a small microneedle patch to collect skin-related samples to help predict how well allergy immunotherapy may work. It includes people with house dust mite allergy and also a healthy control group, so researchers can compare biomarker results.
This study uses a nasal allergen “provocation” test to help decide how to start and monitor allergy immunotherapy (allergy shots or drops). It may help doctors better track whether the treatment is working for people with allergic rhinitis.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.